Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Aberer, W; .
Hereditary angioedema treatment options: The availability of new therapies.
Ann Med. 2012; 44(6):523-529
Doi: 10.3109/07853890.2012.687833
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Aberer Werner
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hereditary angioedema (HAE) is a potentially life-threatening autosomal dominant disease characterized by recurrent episodes of oedema, commonly occurring in the skin, abdomen, and upper respiratory tract. After many years during which limited treatment options were available, a range of newer therapies with proven efficacy have been approved in Europe by the European Commission for the treatment of HAE attacks. However, due to differing legislation and financial restrictions, these treatment options are not available in all countries. Home therapy and self-administration of treatment are recommended in order to minimize the burden of disease upon the patient, with the ideal treatment option being effective, well-tolerated, and easy to prepare and administer. Recently, the Hereditary Angioedema International Working Group (HAWK) consensus recommended early, on-demand treatment for HAE. This article reviews the current treatment options available, and considers the need for treatment guidelines to recommend the appropriate therapy.
- Find related publications in this database (using NLM MeSH Indexing)
- Airway Obstruction - drug therapy Airway Obstruction - economics Airway Obstruction - etiology
- Angioedemas, Hereditary - complications Angioedemas, Hereditary - drug therapy Angioedemas, Hereditary - economics
- Anti-Inflammatory Agents, Non-Steroidal - administration and dosage Anti-Inflammatory Agents, Non-Steroidal - economics Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
- Bradykinin - administration and dosage Bradykinin - analogs and derivatives Bradykinin - economics Bradykinin - therapeutic use
- Complement C1 Inhibitor Protein - administration and dosage Complement C1 Inhibitor Protein - economics Complement C1 Inhibitor Protein - therapeutic use
- Costs and Cost Analysis -
- Costs and Cost Analysis -
- Health Knowledge, Attitudes, Practice -
- Hospitalization - economics
- Humans -
- Insurance Coverage - economics
- Insurance, Pharmaceutical Services - economics Insurance, Pharmaceutical Services - standards
- Legislation, Drug -
- Peptides - administration and dosage Peptides - economics Peptides - therapeutic use
- Physician's Practice Patterns - trends
- Practice Guidelines as Topic -
- Self Administration - economics Self Administration - standards
- Find related publications in this database (Keywords)
- Acute treatment
- hereditary angioedema
- self-administration